Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 357M | |
+42.60% | 748B | |
+32.95% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.87% | 245B | |
+8.46% | 211B | |
-4.54% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals Wins EUR1 Million Grant to Develop Idiopathic Rhinitis Treatment